Chinese ADC Developers Unveil More Target Combos In Bispecific Drive

 
• By Dexter Jie Yan

Chinese developers are racing to roll out bispecific ADCs with different target combinations, while a Biokin/SysImmune executive estimates more than $20bn in annual sales for the company's BMS-partnered EGFR x HER3 candidate, as R&D in the field continues to surge ahead in China.

bispecific approach
bispecific approach to ADC development gains steam in China • Source: Shutterstock

More from China

More from Focus On Asia